Medtric, LLC was founded in 2010 on a vision to deliver scalable and environmentally friendly antimicrobial technologies for use in the medical, industrial and agricultural markets. The company’s core technology is an innovative antimicrobial nanoemulsion. The stable nanoemulsion possess significant antimicrobial activity and scientific studies have shown rapid inactivation (<60 seconds) of multidrug resistant bacteria strains such as MRSA and VRE, fungus and viruses. Medtric has implemented this nanotechnology into products designed initially for wound care, with additional applications in industrial and agricultural sectors.